AAAAAA

   
Results: 1-8 |
Results: 8
TENIPOSIDE (VM-26) AS A SINGLE DRUG-TREATMENT FOR PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CARCINOMA - A PHASE-II STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP
Authors: LOKICH JJ
Citation: Jj. Lokich, TENIPOSIDE (VM-26) AS A SINGLE DRUG-TREATMENT FOR PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CARCINOMA - A PHASE-II STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP, Cancer, 82(5), 1998, pp. 993-993
TREATMENT OF ADVANCED PANCREATIC-CARCINOMA WITH A COMBINATION OF PROTRACTED INFUSIONAL 5-FLUOROURACIL AND WEEKLY CARBOPLATIN - A MID-ATLANTIC ONCOLOGY PROGRAM STUDY
Authors: AUERBACH M WAMPLER GL LOKICH JJ FRYER D FRYER JG AHLGREN JD
Citation: M. Auerbach et al., TREATMENT OF ADVANCED PANCREATIC-CARCINOMA WITH A COMBINATION OF PROTRACTED INFUSIONAL 5-FLUOROURACIL AND WEEKLY CARBOPLATIN - A MID-ATLANTIC ONCOLOGY PROGRAM STUDY, Annals of oncology, 8(5), 1997, pp. 439-444
COMPARISON OF COSTS FOR INFUSION VERSUS BOLUS CHEMOTHERAPY ADMINISTRATION - ANALYSIS OF 5 STANDARD CHEMOTHERAPY REGIMENS IN 3 COMMON TUMORS.1. MODEL PROJECTIONS FOR COST BASED ON CHARGES
Authors: LOKICH JJ MOORE CL ANDERSON NR
Citation: Jj. Lokich et al., COMPARISON OF COSTS FOR INFUSION VERSUS BOLUS CHEMOTHERAPY ADMINISTRATION - ANALYSIS OF 5 STANDARD CHEMOTHERAPY REGIMENS IN 3 COMMON TUMORS.1. MODEL PROJECTIONS FOR COST BASED ON CHARGES, Cancer, 78(2), 1996, pp. 294-299
COMPARISON OF COSTS FOR INFUSION VERSUS BOLUS CHEMOTHERAPY ADMINISTRATION .2. USE OF CHARGES VERSUS REIMBURSEMENT FOR COST BASIS
Authors: LOKICH JJ MOORE CL ANDERSON NR
Citation: Jj. Lokich et al., COMPARISON OF COSTS FOR INFUSION VERSUS BOLUS CHEMOTHERAPY ADMINISTRATION .2. USE OF CHARGES VERSUS REIMBURSEMENT FOR COST BASIS, Cancer, 78(2), 1996, pp. 300-303
HEPATIC METASTATECTOMY FOR LOW-GRADE LEIOMYOSARCOMA - A CASE-REPORT
Authors: LOKICH JJ OLIYNYK PN MCCANDLISH W
Citation: Jj. Lokich et al., HEPATIC METASTATECTOMY FOR LOW-GRADE LEIOMYOSARCOMA - A CASE-REPORT, Cancer investigation, 12(6), 1994, pp. 616-619
RANDOMIZED CLINICAL-TRIAL OF MITOMYCIN-C WITH OR WITHOUT PRETREATMENTWITH WR-2721 IN PATIENTS WITH ADVANCED COLORECTAL-CANCER
Authors: POPLIN EA LORUSSO P LOKICH JJ GULLO JJ LEMING PD SCHULZ JJ VEACH SR MCCULLOCH W BAKER L SCHEIN P
Citation: Ea. Poplin et al., RANDOMIZED CLINICAL-TRIAL OF MITOMYCIN-C WITH OR WITHOUT PRETREATMENTWITH WR-2721 IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Cancer chemotherapy and pharmacology, 33(5), 1994, pp. 415-419
HORMONAL PALLIATION OF CHEMORESISTANT OVARIAN-CANCER - 3 CONSECUTIVE PHASE-II TRIALS OF THE MID-ATLANTIC ONCOLOGY PROGRAM
Authors: AHLGREN JD ELLISON NM GOTTLIEB RJ LALUNA F LOKICH JJ SINCLAIR PR UENO W WAMPLER GL YEUNG KY ALT D FRYER JG
Citation: Jd. Ahlgren et al., HORMONAL PALLIATION OF CHEMORESISTANT OVARIAN-CANCER - 3 CONSECUTIVE PHASE-II TRIALS OF THE MID-ATLANTIC ONCOLOGY PROGRAM, Journal of clinical oncology, 11(10), 1993, pp. 1957-1968
THE SYNDROME OF 5-FLUOROURACIL CARDIOTOXICITY - AN ELUSIVE CARDIOPATHY
Authors: ANDERSON NR LOKICH JJ MOORE C
Citation: Nr. Anderson et al., THE SYNDROME OF 5-FLUOROURACIL CARDIOTOXICITY - AN ELUSIVE CARDIOPATHY, Cancer, 72(7), 1993, pp. 2287-2288
Risultati: 1-8 |